Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

2012 ◽  
Vol 48 (13) ◽  
pp. 2012-2019 ◽  
Author(s):  
Y. Brandberg ◽  
S. Aamdal ◽  
L. Bastholt ◽  
M. Hernberg ◽  
U. Stierner ◽  
...  
2018 ◽  
Vol 13 (1) ◽  
pp. 139-140 ◽  
Author(s):  
Julian Panés ◽  
Séverine Vermeire ◽  
James O Lindsay ◽  
Bruce E Sands ◽  
Chinyu Su ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document